Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Daugaard

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|May 29, 2014
Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trialJ F Christensen, L W Jones, A Tolver, et al.
Leukemia|December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen seriesJ Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsyS D Fosså, N Aass, A Heilo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancerC N Sternberg, H Dumez, H Van Poppel, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
The role of nuclear medicine in the diagnosis of cancer of unknown originH Demir, F Berk, M Raderer, et al.
Andrology|June 10, 2017
Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothersM Bandak, N Jørgensen, A Juul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Multicenter study of human immunodeficiency virus-related germ cell tumorsT Powles, M Bower, G Daugaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)G Daugaard, I Skoneczna, N Aass, et al.
International Journal of Andrology|June 24, 2011
Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculateK Almstrup, M Lippert, H O Mogensen, et al.
British Journal of Cancer|April 15, 2004
Outcome of patients with HIV-related germ cell tumours: a case-control studyT Powles, M Bower, J Shamash, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|May 29, 2014
Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trialJ F Christensen, L W Jones, A Tolver, et al.
Leukemia|December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen seriesJ Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsyS D Fosså, N Aass, A Heilo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancerC N Sternberg, H Dumez, H Van Poppel, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
The role of nuclear medicine in the diagnosis of cancer of unknown originH Demir, F Berk, M Raderer, et al.
Andrology|June 10, 2017
Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothersM Bandak, N Jørgensen, A Juul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Multicenter study of human immunodeficiency virus-related germ cell tumorsT Powles, M Bower, G Daugaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)G Daugaard, I Skoneczna, N Aass, et al.
International Journal of Andrology|June 24, 2011
Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculateK Almstrup, M Lippert, H O Mogensen, et al.
British Journal of Cancer|April 15, 2004
Outcome of patients with HIV-related germ cell tumours: a case-control studyT Powles, M Bower, J Shamash, et al.
Pageof 10